Showing results 3 to 5 of 5
< previous
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
A Phase II study of dasatinib in patients with chemo-sensitive relapsed small cell lung cancer (SCLC): CALGB 30602 Proceeding/Conference:Journal of Thoracic Oncology | 2009 | |||
2017 | ||||
2011 | 17 |